Literature DB >> 27128663

Disease-Induced Skeletal Muscle Atrophy and Fatigue.

Scott K Powers1, Gordon S Lynch, Kate T Murphy, Michael B Reid, Inge Zijdewind.   

Abstract

Numerous health problems, including acute critical illness, cancer, diseases associated with chronic inflammation, and neurological disorders, often result in skeletal muscle weakness and fatigue. Disease-related muscle atrophy and fatigue is an important clinical problem because acquired skeletal muscle weakness can increase the duration of hospitalization, result in exercise limitation, and contribute to a poor quality of life. Importantly, skeletal muscle atrophy is also associated with increased morbidity and mortality of patients. Therefore, improving our understanding of the mechanism(s) responsible for skeletal muscle weakness and fatigue in patients is a required first step to develop clinical protocols to prevent these skeletal muscle problems. This review will highlight the consequences and potential mechanisms responsible for skeletal muscle atrophy and fatigue in patients experiencing acute critical illness, cancer, chronic inflammatory diseases, and neurological disorders.

Entities:  

Mesh:

Year:  2016        PMID: 27128663      PMCID: PMC5069191          DOI: 10.1249/MSS.0000000000000975

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  98 in total

Review 1.  Immune system to brain signaling: neuropsychopharmacological implications.

Authors:  Lucile Capuron; Andrew H Miller
Journal:  Pharmacol Ther       Date:  2011-02-17       Impact factor: 12.310

Review 2.  Cachexia and sarcopenia: mechanisms and potential targets for intervention.

Authors:  Josep M Argilés; Silvia Busquets; Britta Stemmler; Francisco J López-Soriano
Journal:  Curr Opin Pharmacol       Date:  2015-05-14       Impact factor: 5.547

3.  Antibody-directed myostatin inhibition in 21-mo-old mice reveals novel roles for myostatin signaling in skeletal muscle structure and function.

Authors:  Kate T Murphy; René Koopman; Timur Naim; Bertrand Léger; Jennifer Trieu; Chikwendu Ibebunjo; Gordon S Lynch
Journal:  FASEB J       Date:  2010-07-12       Impact factor: 5.191

Review 4.  The TWEAK-Fn14 pathway: a potent regulator of skeletal muscle biology in health and disease.

Authors:  Marjan M Tajrishi; Timothy S Zheng; Linda C Burkly; Ashok Kumar
Journal:  Cytokine Growth Factor Rev       Date:  2013-12-24       Impact factor: 7.638

5.  Cross-talk between the calpain and caspase-3 proteolytic systems in the diaphragm during prolonged mechanical ventilation.

Authors:  W Bradley Nelson; Ashley J Smuder; Matthew B Hudson; Erin E Talbert; Scott K Powers
Journal:  Crit Care Med       Date:  2012-06       Impact factor: 7.598

Review 6.  I'm so tired: biological and genetic mechanisms of cancer-related fatigue.

Authors:  Andrea Barsevick; Marlene Frost; Aeilko Zwinderman; Per Hall; Michele Halyard
Journal:  Qual Life Res       Date:  2010-10-16       Impact factor: 4.147

7.  Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?

Authors:  H J Andreyev; A R Norman; J Oates; D Cunningham
Journal:  Eur J Cancer       Date:  1998-03       Impact factor: 9.162

8.  Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.

Authors:  W D Dewys; C Begg; P T Lavin; P R Band; J M Bennett; J R Bertino; M H Cohen; H O Douglass; P F Engstrom; E Z Ezdinli; J Horton; G J Johnson; C G Moertel; M M Oken; C Perlia; C Rosenbaum; M N Silverstein; R T Skeel; R W Sponzo; D C Tormey
Journal:  Am J Med       Date:  1980-10       Impact factor: 4.965

9.  Elevated expression of activins promotes muscle wasting and cachexia.

Authors:  Justin L Chen; Kelly L Walton; Catherine E Winbanks; Kate T Murphy; Rachel E Thomson; Yogeshwar Makanji; Hongwei Qian; Gordon S Lynch; Craig A Harrison; Paul Gregorevic
Journal:  FASEB J       Date:  2013-12-30       Impact factor: 5.191

Review 10.  Clinical review: intensive care unit acquired weakness.

Authors:  Greet Hermans; Greet Van den Berghe
Journal:  Crit Care       Date:  2015-08-05       Impact factor: 9.097

View more
  45 in total

Review 1.  Endurance exercise protects skeletal muscle against both doxorubicin-induced and inactivity-induced muscle wasting.

Authors:  Scott K Powers; Jose A Duarte; Branden Le Nguyen; Hayden Hyatt
Journal:  Pflugers Arch       Date:  2018-11-13       Impact factor: 3.657

2.  TFAM overexpression diminishes skeletal muscle atrophy after hindlimb suspension in mice.

Authors:  Nicholas T Theilen; Nevena Jeremic; Gregory J Weber; Suresh C Tyagi
Journal:  Arch Biochem Biophys       Date:  2018-12-13       Impact factor: 4.013

3.  A time course for markers of protein synthesis and degradation with hindlimb unloading and the accompanying anabolic resistance to refeeding.

Authors:  Paul A Roberson; Kevin L Shimkus; Jaclyn E Welles; Dandan Xu; Abigale L Whitsell; Eric M Kimball; Leonard S Jefferson; Scot R Kimball
Journal:  J Appl Physiol (1985)       Date:  2020-05-14

4.  Overload-mediated skeletal muscle hypertrophy is not impaired by loss of myofiber STAT3.

Authors:  Joaquín Pérez-Schindler; Mary C Esparza; James McKendry; Leigh Breen; Andrew Philp; Simon Schenk
Journal:  Am J Physiol Cell Physiol       Date:  2017-06-28       Impact factor: 4.249

Review 5.  Fatigue in Rheumatoid Arthritis.

Authors:  Patricia Katz
Journal:  Curr Rheumatol Rep       Date:  2017-05       Impact factor: 4.592

6.  A clinically relevant decrease in contractile force differentially regulates control of glucocorticoid receptor translocation in mouse skeletal muscle.

Authors:  Kirsten R Dunlap; Jennifer L Steiner; Michael L Rossetti; Scot R Kimball; Bradley S Gordon
Journal:  J Appl Physiol (1985)       Date:  2021-02-18

7.  Global alternative splicing landscape of skeletal muscle atrophy induced by hindlimb unloading.

Authors:  Junjie Sun; Hua Yang; Xiaoming Yang; Xin Chen; Hua Xu; Yuntian Shen; Fei Ding; Xiaosong Gu; Jianwei Zhu; Hualin Sun
Journal:  Ann Transl Med       Date:  2021-04

8.  Systemic delivery of a mitochondria targeted antioxidant partially preserves limb muscle mass and grip strength in response to androgen deprivation.

Authors:  Michael L Rossetti; Kirsten R Dunlap; Gloria Salazar; Robert C Hickner; Jeong-Su Kim; Bryant P Chase; Benjamin F Miller; Bradley S Gordon
Journal:  Mol Cell Endocrinol       Date:  2021-07-07       Impact factor: 4.369

9.  Ganoderic acid alleviates chemotherapy-induced fatigue in mice bearing colon tumor.

Authors:  Abudumijiti Abulizi; Ling Hu; Ang Ma; Fang-Yu Shao; Hui-Ze Zhu; Si-Mei Lin; Guang-Ying Shao; Yue Xu; Jian-Hua Ran; Jing Li; Hong Zhou; Dong-Mei Lin; Lian-Fu Wang; Min Li; Bao-Xue Yang
Journal:  Acta Pharmacol Sin       Date:  2021-04-29       Impact factor: 7.169

10.  Androgen depletion alters the diurnal patterns to signals that regulate autophagy in the limb skeletal muscle.

Authors:  Michael L Rossetti; Robert J Tomko; Bradley S Gordon
Journal:  Mol Cell Biochem       Date:  2020-10-31       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.